| Name: | Formoterol EP Impurity I |
| Catalogue No. | VL1700010 |
| CAS No. | 532414-36-1 |
| Molecular Formula | C19H24N2O4 |
| Molecular Weight | 344.41 |
| Status | In-stock |
| IUPAC Name | N-[2-Hydroxy-5-[(1R)-1-hydroxy-2-[[(1S)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]formamide; |
| Synonyms | rel-(R,S)-Formoterol |
| Description | Formoterol EP Impurity I (CAS No. 532414-36-1) or N-[2-Hydroxy-5-[(1R)-1-hydroxy-2-[[(1S)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]formamide s an impurity of Formoterol . Formotero is used to control wheezing, shortness of breath, and chest tightness caused by chronic obstructive pulmonary disease (COPD). |
| References | “Sci-Hub | Formoterol: Pharmacology, Molecular Basis of Agonism, and Mechanism of Long Duration of a Highly Potent and Selective β2-Adrenoceptor Agonist Bronchodilator | 10.1016/0024-3205(93)90729-m.” Hkvisa.net, 2022, sci-hub.hkvisa.net/10.1016/0024-3205(93)90729-m. |
